It is suggested that the increase in circulating leptin could enhance the risk of developing breast cancer when the secretion of proinflammatory cytokines (IL-6, IL-1, IL-17, TNF-α and TGF-β-) is stimulated as well secreted by adipocytes [14,15,16]. This evidence concerns the gene LEP and breast carcinoma.